Izafe Group
0.24 SEK +6.19%Be the first to follow this company
iZafe Group is a Life Science company focused on the development and marketing of digital medical solutions. The company offers products such as Dosell, a pharmaceutical robot, and the SaaS solution Pilloxa, a connected dose bag. The products aim to reduce the risk of incorrect medication. The customers are private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group has its headquarters in Stockholm.
Revenue
1.82M
EBIT %
-1,958.24 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
IZAFE B
Daily low / high price
0.216 / 0.257
SEK
Market cap
66.14M SEK
Turnover
181.6K SEK
Volume
764K
Financial calendar
Interim report
2024-04-26
General meeting
2024-05-30
Interim report
2024-08-30
Interim report
2024-11-01
Annual report
2025-02-14
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Gästrike Nord Invest AB | 16.8 % | 16.4 % |
Stefan Wård | 9.1 % | 8.9 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
iZafe Group's Quarterly Report January-March 2024
KALLELSE TILL ÅRSSTÄMMA I IZAFE GROUP AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools